TGF-β Signaling and Resistance to Cancer Therapy
The transforming growth factor β (TGF-β) pathway, which is well studied for its ability to inhibit cell proliferation in early stages of tumorigenesis while promoting epithelial-mesenchymal transition and invasion in advanced cancer, is considered to act as a double-edged sword in cancer. Multiple i...
Guardado en:
Autores principales: | Maoduo Zhang, Ying Yi Zhang, Yongze Chen, Jia Wang, Qiang Wang, Hezhe Lu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/32246b949cc74d93a2c11dfb1e2ea4b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
por: David J. Benjamin, et al.
Publicado: (2021) -
GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
por: Wang Jian, et al.
Publicado: (2020) -
The Role of TGF-β in Bone Metastases
por: Trupti Trivedi, et al.
Publicado: (2021) -
RNAseq of TGF-β receptor type I kinase-dependent genes in oral fibroblast exposed to milk
por: Layla Panahipour, et al.
Publicado: (2021) -
TGFβ1 Secreted by Cancer-Associated Fibroblasts as an Inductor of Resistance to Photodynamic Therapy in Squamous Cell Carcinoma Cells
por: María Gallego-Rentero, et al.
Publicado: (2021)